GGrantIndex
← Leaderboards

Thomas A Boyd

Progenics Pharmaceuticals, Inc.

$297,048
Attributed
$297,048
Total exposure
1
Grants
0
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$297,048 · 1

By mechanism

R43$297,048 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Analytical Method

Research focus

Analytical MethodAnimal MortalityAntioxidantsAscorbateBlood Brain BarrierBrain CirculationBrain InjuryCerebral Ischemia /HypoxiaChemical StabilityDisease /Disorder ModelDosageDrug Design /Synthesis /ProductionDrug Screening /EvaluationLaboratory MouseMethod DevelopmentNeuropharmacologyNeurophysiologyNeuroprotectantsNonhuman Therapy EvaluationStroke TherapyTransient Ischemic Attack

Grant awards (1)